All Stories

  1. Coordinated epigenetic dysregulation of CNR1 and FAAH genes drives endocannabinoid system dysfunction in anorexia nervosa
  2. Tracking Glucose Trends, Unveiling Clinical Patterns: Insights From Continuous Glucose Monitoring in Patients at the Extreme of BMI and Eating Disorders Psychopathology
  3. Body Image: A Bridge Between Depression and Quality of Life in Women With Cancer
  4. Psychological and Physical Correlates After Gender-Affirming Mastectomy: Insights from a Case Report and Review of the Literature
  5. Early Maladaptive Schemas as Core Therapeutic Targets in Eating Disorders and Obesity: A Schema Therapy–Informed Network Analysis
  6. Bridging Gaps in Obesity Assessment: Spanish Validation of the Eating Behaviors Assessment for Obesity (EBA-O)
  7. Psychological Correlates after Gender-Affirming Mastectomy: Insights from a Case Report and Review of the Literature
  8. Eating behavior assessment for obesity: a reliable tool for detecting binge eating disorder in patients with obesity
  9. Bridging Gaps in Obesity Assessment: Spanish Validation of the Eating Behaviors Assessment for Obesity (EBA-O)
  10. Early Maladaptive Schemas Mediate the Relationship Between Childhood Trauma and Interpersonal Problems in Eating Disorders
  11. Leveraging OGTT derived metabolic features to detect Binge-eating disorder in individuals with high weight: a “seek out” machine learning approach
  12. The Greater the Number of Altered Eating Behaviors in Obesity, the More Severe the Psychopathology
  13. The Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review
  14. Leveraging OGTT derived metabolic features to detect Binge-eating disorder in individuals with high weight: a “seek out” machine learning approach
  15. Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience
  16. Editorial: Psychosocial risk factors in the development, maintenance and treatment outcome of eating disorders
  17. Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia
  18. Applying a clinical staging model in patients affected by schizophrenia spectrum disorder
  19. Metacognition as a transdiagnostic factor across eating disorders: a latent profile analysis study
  20. Effects of school-based physical activity on volition in exercise, sleep quality and internet addiction in Italian adolescents
  21. Validation and assessment of psychometric properties of the Greek Eating Behaviors Assessment for Obesity (GR-EBA-O)
  22. The Effects of Online Home-Based Pilates Combined with Diet on Body Composition in Women Affected by Obesity: A Preliminary Study
  23. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity
  24. Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder
  25. The relationship of food addiction with binge eating disorder and obesity: A network analysis study
  26. Relationship between disgust and orthorexia nervosa and psychometric properties of the Italian Dusseldorf orthorexia scale in a general population sample
  27. Pain experience in eating disorders: The mediating role of depression, alexithymia and interoceptive awareness
  28. Cognitive biases are associated with aberrant salience experience in schizophrenia spectrum disorders
  29. Defining the minimum clinically important difference (MCID) in the hospital anxiety and depression scale (HADS) in patients undergoing total hip and knee arthroplasty
  30. Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
  31. Development, Validation, and Measurement Invariance of the Body Image Bidimensional Assessment (BIBA) in Italian and Spanish Children and Early Adolescent Samples
  32. Does NUCB2/Nesfatin-1 Influence Eating Behaviors in Obese Patients with Binge Eating Disorder? Toward a Neurobiological Pathway
  33. Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
  34. Development, validation and clinical use of the Eating Behaviors Assessment for Obesity (EBA-O)
  35. What do Italian healthcare professionals think about orthorexia nervosa? Results from a multicenter survey
  36. Impaired Metacognitive Differentiation, High Difficulty in Controlling Impulses and Non-acceptance of Emotions are Associated With the Severity of Gambling Disorder
  37. The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review
  38. How Is the History of Early Traumatic Exposure Associated With the Psychopathological Outcomes of COVID-19 Related Lockdown and Subsequent Re-opening in People With Eating Disorders?
  39. Dissociative Symptoms in Bipolar Disorder: Impact on Clinical Course and Treatment Response
  40. Olanzapine-Related Somnambulism
  41. Different clusters of perfectionism in inpatients with anorexia nervosa and healthy controls
  42. Orbito-frontal thinning together with a somatoform dissociation might be the fingerprint of PNES
  43. Executive functions and depressive symptoms interplay in binge eating disorder: A structural equation model analysis
  44. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
  45. Psychological symptoms in dermatologic patients during the COVID-19 lockdown period: a double center experience
  46. COVID-19 pandemic and eating disorders: What impact on specific and general psychopathology?
  47. The impact of COVID-19 lockdown and of the following “re-opening” period on specific and general psychopathology in people with Eating Disorders: the emergent role of internalizing symptoms
  48. Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
  49. Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects
  50. Metacognition and emotion regulation as treatment targets in binge eating disorder: a network analysis study
  51. Clinical Impact of Psychopathy on Bipolar Disorder
  52. Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study
  53. IMPACT OF BIPOLAR DISORDER AND OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY ON NEUROCOGNITIVE PROFILE: A MINI-REVIEW
  54. A systematic review on the role of microbiota in the pathogenesis and treatment of eating disorders
  55. Validation of the body image dimensional assessment in adolescents from Spanish high school
  56. Pathways to orthorexia nervosa: a case series discussion
  57. Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review
  58. The role of self‐monitoring metacognition sub‐function and negative urgency related to binge severity
  59. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder
  60. The Young Schema Questionnaire Short Form 3 (YSQ-S3): does the new four-domains model show the best fit?
  61. Personality traits predict residual pain after total hip and knee arthroplasty
  62. Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study
  63. The Potential Role of the Early Maladaptive Schema in Behavioral Addictions Among Late Adolescents and Young Adults
  64. Adverse childhood experiences and clinical severity in bipolar disorder and schizophrenia: A transdiagnostic two-step cluster analysis
  65. How are early maladaptive schemas and DSM‐5 personality traits associated with the severity of binge eating?
  66. Food Addiction in Eating Disorders and Obesity: Analysis of Clusters and Implications for Treatment
  67. Thrombocytosis in bipolar disorder: A case report
  68. Brain-Behavior-Immune Interaction: Serum Cytokines and Growth Factors in Patients with Eating Disorders at Extremes of the Body Mass Index (BMI) Spectrum
  69. Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms
  70. ‘Impaired Autonomy and Performance’ predicts binge eating disorder among obese patients
  71. Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
  72. The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: A systematic review
  73. Pathways to specialist care for eating disorders: An Italian multicentre study
  74. Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy
  75. Maternal stress, prenatal medical illnesses and obstetric complications: Risk factors for schizophrenia spectrum disorder, bipolar disorder and major depressive disorder
  76. Childhood adversities are different in Schizophrenic Spectrum Disorders, Bipolar Disorder and Major Depressive Disorder
  77. Motivation in non-sedentary subjects over fifty age: state of physical and mental health
  78. Weight and age do not account for a worse executive functioning among BED-obese patients
  79. Effectiveness of integrated psychological therapy on clinical, neuropsychological, emotional and functional outcome in schizophrenia: a RCT study
  80. A CASE REPORT OF AN ADULT MALE PATIENT WITH AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER TREATED WITH CBT
  81. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile
  82. Effect of type D personality on smoking status and their combined impact on outcome after acute myocardial infarction
  83. A real world study on the genetic, cognitive and psychopathological differences of obese patients clustered according to eating behaviours
  84. Italian validation of the Grazing Questionnaire: analysis of psychometric properties
  85. Validation of the Italian version of the Yale Food Addiction Scale 2.0 (I-YFAS 2.0) in a sample of undergraduate students
  86. Short-Term Treatment Outcomes and Dropout Risk in Men and Women with Eating Disorders
  87. Are coping strategies really different among family members of patients with eating disorders?
  88. Lithium in late-life mania: a systematic review
  89. Social Cognition and Emotional Functioning in Patients with Binge Eating Disorder
  90. The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders
  91. Binge Eating Disorder and Bipolar Spectrum Disorders in Obesity: Psychopathological and eating behaviors differences according to comorbidities
  92. Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients
  93. Anxiety and depression mediate the role of low self-esteem and low self-directedness in the development of eating disorders
  94. How do relatives cope with eating disorders? Results from an Italian multicentre study
  95. Physical Activity and Health Perception in Aging: Do Body Mass and Satisfaction Matter? A Three-Path Mediated Link
  96. Hospitalization and other risk factors for depressive and anxious symptoms in oncological and non-oncological patients
  97. Unemployment, perceived health status and coping: A study in Southern Italy
  98. Ability of EDI-2 and EDI-3 to correctly identify patients and subjects at risk for eating disorders
  99. Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile
  100. Rare and very rare adverse effects of clozapine
  101. Depressive symptoms in caregivers of patients with dementia: demographic variables and burden
  102. Religiousness and spirituality in patients with bipolar disorder
  103. Decision making, central coherence and set-shifting: a comparison between Binge Eating Disorder, Anorexia Nervosa and Healthy Controls
  104. The prevalence of orthorexia nervosa among eating disorder patients after treatment
  105. Development and validation of the family coping questionnaire for eating disorders
  106. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine
  107. Use of atypical antipsychotics in the elderly: a clinical review
  108. Food choice in disorders of eating behavior: Correlations with the psychopathological aspects of the diseases
  109. Body Image, Body Satisfaction, and Eating Attitudes in Master Athletes, Physically Active and Sedentary Older Individuals.
  110. Temperamental factors predict long-term modifications of eating disorders after treatment
  111. Mental Adjustment to Cancer: The Role of Anxious and Depressive Symptoms under Treatment
  112. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals
  113. Therapeutic options for binge eating disorder
  114. Specific Personality Traits and Coping Styles Predict Affective Symptoms in Early Post Acute Coronary Syndrome Inpatients
  115. Commentary
  116. Body Uneasiness, Eating Disorders, and Muscle Dysmorphia in Individuals Who Overexercise
  117. Sertraline-Induced Rhabdomyolysis in an Elderly Patient with Dementia and Comorbidities
  118. Olanzapine therapy in anorexia nervosa: psychobiological effects
  119. Generalised Urticaria in a Young Woman treated with Clomipramine and after Ingestion of Codfish